[go: up one dir, main page]

DK0732913T3 - Syntetisk viskoelastisk materiale til fysiologiske anvendelser, såsom oftalmiske anvendelser - Google Patents

Syntetisk viskoelastisk materiale til fysiologiske anvendelser, såsom oftalmiske anvendelser

Info

Publication number
DK0732913T3
DK0732913T3 DK94928700T DK94928700T DK0732913T3 DK 0732913 T3 DK0732913 T3 DK 0732913T3 DK 94928700 T DK94928700 T DK 94928700T DK 94928700 T DK94928700 T DK 94928700T DK 0732913 T3 DK0732913 T3 DK 0732913T3
Authority
DK
Denmark
Prior art keywords
applications
composition
physiological
viscoelastic material
ophthalmic
Prior art date
Application number
DK94928700T
Other languages
English (en)
Inventor
Bradford C Webb
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DK0732913T3 publication Critical patent/DK0732913T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
DK94928700T 1993-04-30 1994-04-06 Syntetisk viskoelastisk materiale til fysiologiske anvendelser, såsom oftalmiske anvendelser DK0732913T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5582293A 1993-04-30 1993-04-30
PCT/US1994/003749 WO1994025004A1 (en) 1993-04-30 1994-04-06 Synthetic viscoelastic material for ophthalmic applications

Publications (1)

Publication Number Publication Date
DK0732913T3 true DK0732913T3 (da) 2003-06-16

Family

ID=22000374

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94928700T DK0732913T3 (da) 1993-04-30 1994-04-06 Syntetisk viskoelastisk materiale til fysiologiske anvendelser, såsom oftalmiske anvendelser

Country Status (12)

Country Link
US (2) US5422376A (da)
EP (1) EP0732913B1 (da)
JP (1) JP2976350B2 (da)
KR (1) KR100246016B1 (da)
AT (1) ATE233083T1 (da)
AU (1) AU681146B2 (da)
CA (1) CA2161774C (da)
DE (1) DE69432188T2 (da)
DK (1) DK0732913T3 (da)
ES (1) ES2192560T3 (da)
RU (1) RU2145882C1 (da)
WO (1) WO1994025004A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
BR0109162A (pt) 2000-03-14 2005-01-11 Alcon Inc Viscoelásticos para uso na cirurgia do ouvido médio
US20030086899A1 (en) * 2000-03-14 2003-05-08 Jafari Masoud R. Chondroitin sulfate containing viscoelastics for use in treating joints
RU2200519C2 (ru) * 2000-05-15 2003-03-20 Ченчик Александр Дмитриевич Способ газовой тампонады при проведении офтальмологических полостных операций
AU2000268609A1 (en) * 2000-09-14 2002-03-26 Robert Theiler Intraarticular agent for the treatment of osteoarthritis
BR0115154A (pt) * 2000-11-06 2006-06-06 Alcon Inc material viscoelástico transicional não-aspirante para uso em cirurgia
US6756363B1 (en) * 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan
AU2895502A (en) * 2000-12-20 2002-07-01 Alcon Universal Ltd Solution for removing cataracts via liquefracture
WO2003011257A1 (en) * 2001-08-01 2003-02-13 Jasjit Singh Composition and process the manufacture of soluble containers with improved gel-strength
US20040101561A1 (en) * 2002-11-13 2004-05-27 Jafari Masoud R. Combinations of viscoelastics for use during surgery
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US20120283232A9 (en) * 2003-11-12 2012-11-08 Zhengjun Wang Process for making a pharmaceutical composition
US20050215515A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo Viscoelastic composition, method of use and package
US20060159651A1 (en) * 2005-01-14 2006-07-20 Michael Colvard Gradient molecular weight viscoelastic solutions
RU2310327C1 (ru) * 2006-03-24 2007-11-20 Владимир Николаевич Канюков Способ консервации донорских тканей для офтальмохирургии
RU2600863C2 (ru) * 2007-12-10 2016-10-27 Сентисс Фарма Прайвит Лимитед Офтальмическая композиция, включающая фенилэфрин
DE102009037514A1 (de) * 2009-08-17 2011-03-10 Dirk-Henning Dr. Menz Wasserlösliche Polysaccharidether und ihre Verwendung
US8845624B2 (en) * 2010-06-25 2014-09-30 Alcon LexSx, Inc. Adaptive patient interface
CN105164204A (zh) 2012-11-21 2015-12-16 路易斯维尔大学研究基金会 用于降低氧化损伤的组合物和方法
WO2014100403A1 (en) * 2012-12-19 2014-06-26 Kashiv Pharma, Llc Supersaturated stabilized nanoparticles for poorly soluble drugs
DE102014103512A1 (de) 2014-03-14 2015-09-17 Carl Zeiss Meditec Ag Injektor zur Injektion eines Operations-Hilfsfluids in ein Auge sowie Verfahren zum Erzeugen eines Operations-Hilfsfluids
EP3256136A4 (en) 2015-02-09 2018-11-21 University Of Louisville Research Foundation, Inc. Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
WO2022172089A1 (en) * 2021-02-12 2022-08-18 I Optima Ltd. Compound, method and system for ophthalmic surgery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
DE3416777C2 (de) * 1984-05-07 1986-11-20 Gödecke AG, 1000 Berlin Pharmazeutische topische Zubereitungen
JPS62122671A (ja) * 1985-11-23 1987-06-03 千寿製薬株式会社 眼内手術用高粘性液の製造法
JPH0657245B2 (ja) * 1986-05-14 1994-08-03 ト−メ−産業株式会社 眼科手術用粘弾性溶液
US4819617A (en) * 1986-09-04 1989-04-11 University Of Florida Viscoelastic material for ophthalmic surgery
CA1317226C (en) * 1987-05-04 1993-05-04 Phillip E. Pennell Viscoelastic fluid for ophthalmic surgery and method of using same
US4853374A (en) * 1987-06-09 1989-08-01 M.D.R. Group, Inc. Viscoelastic vitreous substitute with UV blocker
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5218107A (en) * 1991-12-30 1993-06-08 The Dow Chemical Company Removal of undesirable material from water-soluble cellulose ether aqueous solutions

Also Published As

Publication number Publication date
JP2976350B2 (ja) 1999-11-10
CA2161774A1 (en) 1994-11-10
DE69432188T2 (de) 2004-01-22
ES2192560T3 (es) 2003-10-16
WO1994025004A1 (en) 1994-11-10
EP0732913B1 (en) 2003-02-26
AU681146B2 (en) 1997-08-21
CA2161774C (en) 2000-01-04
EP0732913A1 (en) 1996-09-25
JPH09507469A (ja) 1997-07-29
DE69432188D1 (de) 2003-04-03
US5422376A (en) 1995-06-06
AU6700894A (en) 1994-11-21
RU2145882C1 (ru) 2000-02-27
KR100246016B1 (ko) 2000-04-01
ATE233083T1 (de) 2003-03-15
HK1019005A1 (en) 2000-01-14
USRE42243E1 (en) 2011-03-22

Similar Documents

Publication Publication Date Title
DK0732913T3 (da) Syntetisk viskoelastisk materiale til fysiologiske anvendelser, såsom oftalmiske anvendelser
US4863907A (en) Crosslinked glycosaminoglycans and their use
CA1240929A (en) Chondroitin sulfate/sodium hyaluronate compositions
EA199800689A1 (ru) Офтальмологические растворы, загущенные с помощью полисахаридов семян тамаринда
FI963217A0 (fi) Nestemäinen oftalminen, hidastetusti vapauttava antosysteemi
NO180668C (no) Kryss-bundede, sårsekretabsorberende hydrogeler
EP0676207A3 (fr) Agent anticomplémentaire obtenu à partir de fucanes d'algues brunes
US6051560A (en) Chrondroitin sulfate/sodium hyaluronate composition
DK0696297T3 (da) Pyridobisimidazolbaseret stiv stavpolymer
DE69023163D1 (de) Natriumhyaluronat-Zusammensetzung.
CA2070293A1 (en) Ophthalmic compositions and methods for preserving and using same
NO177845C (no) Fremgangsmåte for fremstilling av et preparat for öyedråper
AU697005B2 (en) Implantable molded articles for the administration of active substances to plants
AU8889891A (en) Pharmaceutical compositions
DK0883408T3 (da) Ophthalmologisk anvendelig sammentsætning, produkter indeholdende sammensætningen og fremgangsmåde til desinfektion og/eller rensning af kontaktlinser
HUT59011A (en) Process for producing composition, and its active ingredient, suitable for inactivating or removing harmful compounds in blood and other extracellular liquids
CA1140469A (en) Hyaluronate based compositions and cosmetic formulations containing same
DE69614577D1 (de) Polyamin-antagonisten enthaltende intraokulare irrigationslösung
RU97113443A (ru) Способ лечения ожогов глаз
IT8603594A0 (it) Composizioni ad uso oftalmico a funzione di lacrima artificiale uso di particolari sostanze in composizioni ad uso oftalmico con la funzione detta ed uso di queste sia nelle patologie legate alla qualita' e/o quantita'del liquido lacrimale secreto,sia come ausilio nell'uso delle lenti corneali
CA1273296C (en) SOLUBLE COLLAGEN COMPOSITION
RU93015155A (ru) Лекарственное средство для лечения дистрофических заболеваний и травм глазных тканей